NCT04078893 is a NA clinical trial of telephone recruitment in Blood Donors, sponsored by Guangzhou Blood Center.

Who is sponsoring NCT04078893?

NCT04078893 is sponsored by Guangzhou Blood Center.

What drugs are being tested in NCT04078893?

Interventions in NCT04078893: telephone recruitment.

What condition does NCT04078893 study?

NCT04078893 studies Blood Donors.

Is NCT04078893 still recruiting?

NCT04078893 is currently status unknown. Last updated 21 October 2019.

Last reviewed 2019-10-21 · How we verify

NCT04078893

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Recruiting Inactive Blood Donors Using Different Means

Status unknown NA Last updated 21 October 2019

What this trial tests

NA trial testing telephone recruitment in Blood Donors in 14,098 participants. Status unknown.

Timeline

20 October 2019

Primary endpoint
29 November 2019

29 January 2020

Quick facts

Lead sponsor	Guangzhou Blood Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	14,098
Start date	20 October 2019
Primary completion	29 November 2019
Estimated completion	29 January 2020
Sites	1 location across China

Drugs / interventions tested

telephone recruitment

Conditions studied

Blood Donors — all drugs for Blood Donors →

Sponsor

Guangzhou Blood Center — full company profile →

Who can join

Adults 18 to 60, any sex, with Blood Donors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

14098 inactive donors were randomly divided into three groups according to age, sex, blood donation frequency,time of last donation and blood donation site, one group acted as the control group, one will be recruited by telephone recruitment on "need", and one will just be called for improvement suggestions of blood donor service.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Blood Donors

Currently open trials in the same condition.

NCT00001846 — Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use · recruiting

Other Guangzhou Blood Center trials

Trials by the same sponsor.

NCT05213130 — Blood Donation and Subjective Well-being · NA · completed
NCT05319951 — Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation · NA · completed
NCT04484896 — Message Framing on Recruiting Rh-D Negative Blood Donors · NA · unknown
NCT04431180 — Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# · NA · unknown
NCT04410458 — Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04078893 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guangzhou Blood Center
Last refreshed: 21 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04078893.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing